News
ArgusEye closes €2.8 million funding to accelerate bioprocessing
Today we’re announcing an oversubscribed funding round of 2.8 M [...]
ArgusEye introduces AugaOne™ to accelerate downstream bioprocess development
• AugaOne™ sensor system provides specific, real-time, and automated data to [...]
The Countdown Begins: Just Two Months Until the Exciting Launch of AugaOne™!
With the product launch swiftly approaching, ArgusEye offers an exclusive sneak [...]
ArgusEye selected for TESTA Challenge 2022
ArgusEye has again been selected to participate in TESTA Challenge hosted by TESTA Center in Uppsala, Sweden. This is the second edition of TESTA Challenge which is organized by TESTA Center and STUNS in collaboration with Cytiva. RISE and Pall. The aim of this [...]
ArgusEye completes oversubscribed seed funding round
ArgusEye has successfully completed its first external financing round, securing additional funding for further product development and team expansion. The strong investor syndicate in this oversubscribed funding round is led by Eir Ventures and ALMI Invest together with 10 life science experienced business angels. NY [...]
A successful week for ArgusEye during TESTA Challenge 2020
During October 19-23, ArgusEye participated in TESTA Challenge in Uppsala. This is a new initiative organized by TESTA Center, STUNS and Cytiva. The objective is to allow small start-up companies (like ArgusEye) to validate new and innovative methods and technologies to improve the production [...]
ArgusEye selected for TESTA Challenge 2020
ArgusEye has been selected to participate in TESTA Challenge 2020 hosted by TESTA Center in Uppsala, Sweden TESTA Challenge is a new initiative organized by TESTA Center in collaboration with Cytiva, Region Uppsala and STUNS. The aim of this initiative is to allow small [...]
ArgusEye at NLS Days 2019, September 10-12
ArgusEye’s CEO Dr. Erik Martinsson will participate at the Nordic Life Science Days 2019 Nordic Life Science Days 2019 will take place on September 10-12 in Malmö, Sweden. ArgusEye’s CEO Dr. Erik Martinsson will be participating and is available for in-depth discussion about our [...]
ArgusEye receives new grant from Vinnova
In tough competition with other innovative start-up companies, ArgusEye is granted 900 000 SEK from Vinnova’s program Innovative Startups Step 2. In September 2017, ArgusEye received a grant through Vinnova’s program Innovative Startups Step 1. The grant allowed ArgusEye to conduct a market analysis to [...]